Our results demonstrated that the Tet-inducible artificial microRNAs targeting β-catenin and HIF-1α can be used to effectively silence the cancer-related genes and inhibit malignant phenotypes of bladder cancer cells in a dosage-dependent manner. The gene discussed is HIF1A; the disease is urinary bladder carcinoma.